The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Stealth PLA-PEG Nanoparticles as Protein Carriers for Nasal Administration
Abstract
Purpose The aim of the study was to encapsulate a model protein antigen, tetanus toxoid (TT), within hydrophobic (PLA) and surface hydrophilic (PLA-PEG) nanoparticles and to evaluate the potential of these colloidal carriers for the transport of proteins through the nasal mucosa. Methods TT-loaded nanoparticles, prepared by a modified water-in-oil-in-water solvent evaporation technique, were characterized in their size, zeta potential and hydrophobicity. Nanoparticles were also assayed in vitro for their ability to deliver active antigen for extended periods of time. Finally, 125I-TT-loaded nanoparticles were administered intranasally to rats and the amount of radioactivity recovered in the blood compartment, lymph nodes and other relevant tissues was monitored for up to 48 h. Results PLA and PLA-PEG nanoparticles had a similar particle size (137-156 nm) and negative surface charge, but differed in their surface hydrophobicity: PLA were more hydrophobic than PLA-PEG nanoparticles. PLA-PEG nanoparticles, especially those containing gelatine as an stabilizer, provided extended delivery of the active protein. The transport of the radiolabeled protein through the rat nasal mucosa was highly affected by the surface properties of the nanoparticles: PLA-PEG nanoparticles led to a much greater penetration of TT into the blood circulation and the lymph nodes than PLA nanoparticles. Furthermore, after administration of 125I-TT-loaded PLA-PEG nanoparticles, it was found that a high amou…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This layer of PEG acts as a barrier and reduces the interactions with foreign molecules by steric and hydrated repulsion, giving enhanced shelf stability [22].”
From Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier (2011) · cites this paper as [22]
Citations
Cites
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V. S., Torchilin, V. P., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,951
Self-citationEldridge, J. H., Hammond, C., Meulbroek, J. A., Staas, J. K., Gilley, R. M., & Tice, T. R. (1990) · Journal of Controlled Release · doi:10.1016/0168-3659(90)90133-e · Cited by 689
Stealth Me. PEG‐PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes System
Bazile, D., Prud'homme, C., Bassoullet, M., Marlard, M., Spenlehauer, G., & Veillard, M. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840420 · Cited by 635
The role of nasopharyngeal lymphoid tissue
Kuper, C. F., Koornstra, P. J., Hameleers, D. M. H., Biewenga, J., Spit, B. J., Duijvestijn, A. M., Vriesman, P. J. C. V. B., & Sminia, T. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90158-4 · Cited by 537
The Oral Absorption of Micro- and Nanoparticulates: Neither Exceptional Nor Unusual
Florence, A. T. (1997) · Pharmaceutical Research · doi:10.1023/a:1012029517394 · Cited by 498
Stolnik, S., Dunn, S. E., Garnett, M. C., Davies, M. C., Coombes, A. G. A., Taylor, D. C., Irving, M. P., Purkiss, S. C., Tadros, T. F., Davis, S. S., et al. (1994) · Pharmaceutical Research · doi:10.1023/a:1018931820564 · Cited by 292
Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres
Blanco, M., & Alonso, M. J. (1997) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00056-8 · Cited by 270
Self-citationPeracchia, M. T., Gref, R., Minamitake, Y., Domb, A. J., Lotan, N., & Langer, R. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(96)01597-0 · Cited by 266
Self-citationDeterminants of Release Rate of Tetanus Vaccine from Polyester Microspheres
Alonso, M. J., Cohen, S., Park, T. G., Rk, G., Siber, G. R., & Langer, R. (1993) · Pharmaceutical Research · doi:10.1023/a:1018942118148 · Cited by 223
Self-citationAlmeida, A. J., & Alpar, H. O. (1996) · Journal of drug targeting · doi:10.3109/10611869609015965 · Cited by 117
Research works printed but not linked: 5
- D. T. O'Hagan. Clin. Pharmacokinet. 22:335–344 (1992).
- P. Wüthrich and P. Buri. Pharm. Acta Helvetiae 64:322–331 (1989).
- M. J. Alonso, B. Villamayor, M. Tobío, S. Schwendeman, R. K. Gupta, G. Siber, and R. Langer. Proceed. Intern. Symp. Rel. Bioact. Mater. 23:825–826 (1996).
- M. Tobío and M. J. Alonso. Proceed. Intern. Symp. Rel. Bioact. Mater. 24:425–426 (1997).
- A. T. Florence and P. U. Jani. Pharmaceutical Particulate Carriers, Marcel Dekker, New York, 1993, pp. 65–108.
Cited by
Sorted by citations
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Makadia, H. K., & Siegel, S. J. (2011) · Polymers · doi:10.3390/polym3031377 · Cited by 4,816
“This layer of PEG acts as a barrier and reduces the interactions with foreign molecules by steric and hydrated repulsion, giving enhanced shelf stability [22].”
BackgroundPEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Inorganic Nanoparticles for MRI Contrast Agents
Na, H. B., Song, I. C., & Hyeon, T. (2009) · Advanced Materials · doi:10.1002/adma.200802366 · Cited by 1,811
Nano-engineering block copolymer aggregates for drug delivery
Allen, C., Maysinger, D., & Eisenberg, A. (1999) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00058-2 · Cited by 1,358
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles
Reis, C. P., Neufeld, R. J., Ribeiro, A. J., & Veiga, F. (2006) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2005.12.003 · Cited by 1,355
Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
des Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J., & Préat, V. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.013 · Cited by 1,305
Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine
Akbarzadeh, A., Samiei, M., & Davaran, S. (2012) · Nanoscale Research Letters · doi:10.1186/1556-276x-7-144 · Cited by 1,271
Sahoo, S. K., Panyam, J., Prabha, S., & Labhasetwar, V. D. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00127-x · Cited by 1,008
Polysaccharide colloidal particles as delivery systems for macromolecules
Janes, K. A., Calvo, P., & Alonso, M. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00123-x · Cited by 900
Self-citationSynthetic Nanoparticles for Vaccines and Immunotherapy
Irvine, D. J., Hanson, M. C., Rakhra, K., & Tokatlian, T. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00109 · Cited by 779
Design of biodegradable particles for protein delivery
Vila, A., Sánchez, A., Tobío, M. T. B., Calvo, P., & Alonso, M. J. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00486-2 · Cited by 620
Self-citationChitosan-Based Particles as Controlled Drug Delivery Systems
Prabaharan, M., & Mano, J. F. (2004) · Drug Delivery · doi:10.1080/10717540590889781 · Cited by 564
Oyewumi, M. O., Kumar, A., & Cui, Z. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.89 · Cited by 564
PEGylated PLGA nanoparticles as protein carriers: Synthesis, preparation and biodistribution in rats
Li, Y.-P., Pei, Y.-Y., Zhang, X.-Y., Gu, Z.-H., Zhou, Z.-H., Yuan, W.-F., Zhou, J.-J., Zhu, J.-H., & Gao, X.-J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00218-8 · Cited by 540
Üner, M., & Yener, G. (2007) · PubMed Central · Cited by 536
Targeted nanoparticles for cancer therapy
Gu, F., Karnik, R., Wang, A. Z., Alexis, F., Levy‐Nissenbaum, E., Hong, S., Langer, R., & Farokhzad, O. C. (2007) · Nano Today · doi:10.1016/s1748-0132(07)70083-x · Cited by 520
Self-citationPolymeric nanoparticulate system: A potential approach for ocular drug delivery
Nagarwal, R. C., Kant, S., Singh, P., Maiti, P., & Pandit, J. K. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.12.018 · Cited by 481
Nanocarriers: Promising Vehicle for Bioactive Drugs
Rawat, M. S., Singh, D., Saraf, S., & Saraf, S. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.1790 · Cited by 449
Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice
Vila, A., Sánchez, A., Janes, K. A., Behrens, I., Kissel, T., Jato, J. L. V., & Alonso, M. J. (2003) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2003.09.006 · Cited by 449
Self-citationShum, H. C., Kim, J., & Weitz, D. A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja802157y · Cited by 444
Drug transport to brain with targeted nanoparticles
Olivier, J. (2004) · NeuroRx · doi:10.1602/neurorx.2.1.108 · Cited by 452
Martins, S., Sarmento, B. F. C. C., Ferreira, D., & Souto, E. B. (2007) · PubMed Central · Cited by 399
Gandhi, N. S., Tekade, R. K., & Chougule, M. B. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.09.001 · Cited by 402
Behrens, I., Pena, A. I. V., Alonso, M. J., & Kissel, T. (2002) · Pharmaceutical Research · doi:10.1023/a:1019854327540 · Cited by 377
Self-citationTobío, M. T. B., Sánchez, A., Vila, A., Soriano, I., Évora, C., Vila-Jato, J. L., & Alonso, M. J. (2000) · Colloids and Surfaces B Biointerfaces · doi:10.1016/s0927-7765(99)00157-5 · Cited by 367
Self-citationNew frontiers in nanotechnology for cancer treatment
Alexis, F., Rhee, J., Richie, J. P., Radovic‐Moreno, A. F., Langer, R., & Farokhzad, O. C. (2008) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.03.017 · Cited by 361
Self-citationChitosan-based drug nanocarriers: Where do we stand?
García-Fuentes, M., & Alonso, M. J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.017 · Cited by 354
Self-citationPLGA-Based Composites for Various Biomedical Applications
Rocha, C. V., Gonçalves, V., da Silva, M. C., Bañobre‐López, M., & Gallo, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042034 · Cited by 379
Nanoparticles for Biomedical Imaging: Fundamentals of Clinical Translation
Choi, H. S., & Frangioni, J. V. (2010) · Molecular Imaging · doi:10.2310/7290.2010.00031 · Cited by 361
Transmucosal macromolecular drug delivery
Prego, C., García-Fuentes, M., Torres, D., & Alonso, M. J. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.030 · Cited by 345
Self-citationColloidal drug carriers: achievements and perspectives
BARRATT, G. M. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s000180300002 · Cited by 334
Assessment of PEG on polymeric particles surface, a key step in drug carrier translation
Rabanel, J., Hildgen, P., & Banquy, X. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.017 · Cited by 327
Perez, C., Sanchez, A., Putnam, D., Ting, D., Langer, R., & Alonso, M. J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00397-2 · Cited by 313
Self-citationNanomedicines for overcoming biological barriers
Alonso, M. J. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.01.007 · Cited by 312
Self-citationChitosan–PEG nanocapsules as new carriers for oral peptide delivery
Prego, C., Torres, D., Fernández-Megía, E., Novoa-Carballal, R., Quiñoá, E., & Alonso, M. J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.12.015 · Cited by 308
Self-citationOral insulin delivery by means of solid lipid nanoparticles.
Sarmento, B. F. C. C., Martins, S., Ferreira, D., & Souto, E. B. (2007) · PubMed Central · Cited by 299
Gao, X., Tao, W., Lü, W., Zhang, Q., Zhang, Y., Jiang, X., & Fu, S. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.01.038 · Cited by 300
Moving smaller in drug discovery and delivery
LaVan, D. A., Lynn, D. M., & Langer, R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd707 · Cited by 287
Self-citationDouble emulsions prepared by two–step emulsification: History, state-of-the-art and perspective
Ding, S., Serra, C. A., Vandamme, T., Yu, W., & Anton, N. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.037 · Cited by 283
Nanoparticles for nasal vaccination
Csaba, N., García-Fuentes, M., & Alonso, M. J. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.005 · Cited by 285
Self-citationBiofunctionalized targeted nanoparticles for therapeutic applications
Wang, A. Z., Gu, F., Zhang, L., Chan, J. M., Radovic-Moreno, A., Shaikh, M. R., & Farokhzad, O. C. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.8.1063 · Cited by 277
Kwon, S., Park, J. H., Chung, H., Kwon, I. C., Jeong, S. Y., & Kim, I.-S. (2003) · Langmuir · doi:10.1021/la0350608 · Cited by 269
Hu, Y., Jiang, X., Ding, Y., Zhang, L., Yang, C., Zhang, J., Chen, J., & Yang, Y. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00021-8 · Cited by 261
Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery
Mody, K. T., Popat, A., Mahony, D., Cavallaro, A. S., Yu, C., & Mitter, N. (2013) · Nanoscale · doi:10.1039/c3nr00357d · Cited by 264
Magnetic targeting for site-specific drug delivery: applications and clinical potential
Polyak, B., & Friedman, G. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240802662795 · Cited by 261
Park, K., Kim, J., Nam, Y. S., Lee, S., Nam, H. Y., Kim, K., Park, J. H., Kim, I., Choi, K., Kim, S. Y., et al. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.04.009 · Cited by 257
Vila, A., Gill, H., McCallion, O. N. M., & Alonso, M. J. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.04.026 · Cited by 249
Self-citationWen, Z., Yan, Z., Hu, K., Pang, Z., Cheng, X., Guo, L., Zhang, Q., Jiang, X., Fang, L., & Lai, R. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.02.022 · Cited by 241
Cyclodextrin based nanosponges for pharmaceutical use: A review
Gursalkar, T., Amrita, B., & Darshana, J. (2013) · Acta Pharmaceutica · doi:10.2478/acph-2013-0021 · Cited by 246
Nanoparticulate Systems for Nasal Delivery of Drugs: A Real Improvement over Simple Systems?
Illum, L. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20718 · Cited by 238
Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study
Vandervoort, J., & Ludwig, A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00058-3 · Cited by 237
Lectin-mediated mucosal delivery of drugs and microparticles
Clark, M. A., Hirst, B. H., & Jepson, M. A. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00070-3 · Cited by 236
De Campos, A. M., Sánchez, A., Gref, R., Calvo, P., & Alonso, M. J. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(03)00178-7 · Cited by 234
Self-citationReis, C. P., Neufeld, R. J., Ribeiro, A. J., & Veiga, F. (2006) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2006.04.009 · Cited by 214
Avgoustakis, K. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00224-2 · Cited by 211
Gao, X., Wu, B., Zhang, Q., Chen, J., Zhu, J., Zhang, W., Rong, Z., Chen, H., & Jiang, X. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.026 · Cited by 207
Transport of Nanoparticles Across the Rat Nasal Mucosa
Brooking, J., Davis, S. S., & Illum, L. (2001) · Journal of drug targeting · doi:10.3109/10611860108997935 · Cited by 206
Self-Assembled Polyelectrolyte Nanocomplexes between Chitosan Derivatives and Insulin
Mao, S., Bakowsky, U., Jintapattanakit, A., & Kissel, T. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20520 · Cited by 205
Solid Lipid Nanoparticles (SLN): Method, Characterization and Applications
Garud, A., Singh, D., & Garud, N. (2012) · International Current Pharmaceutical Journal · doi:10.3329/icpj.v1i11.12065 · Cited by 203
Zhang, C., Chen, J., Feng, C., Shao, X., Liu, Q., Zhang, Q., Pang, Z., & Jiang, X. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.11.049 · Cited by 198
Surface-engineered nanoparticles for multiple ligand coupling
Gref, R., Couvreur, P., BARRATT, G. M., & Mysiakine, E. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00348-x · Cited by 196
Self-citationPolymer micelles with cross-linked ionic cores for delivery of anticancer drugs
Bontha, S., Kabanov, A. V., & Bronich, T. K. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.06.015 · Cited by 196
Chitosan-coated solid lipid nanoparticles enhance the oral absorption of insulin
Fonte, P., Nogueira, T., Gehm, C., Ferreira, D., & Sarmento, B. F. C. C. (2011) · Drug Delivery and Translational Research · doi:10.1007/s13346-011-0023-5 · Cited by 191
Lamprecht, A., Ubrich, N., Hombreiro Pérez, M., Lehr, C.-M., Hoffman, M., & Maincent, P. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00422-6 · Cited by 185
Mukhopadhyay, P., Sarkar, K., Chakraborty, M., Bhattacharya, S., Mishra, R., & Kundu, P. P. (2012) · Materials Science and Engineering C · doi:10.1016/j.msec.2012.09.001 · Cited by 184
Kim, K., Kwon, S., Park, J. H., Chung, H., Jeong, S. Y., Kwon, I. C., & Kim, I. (2005) · Biomacromolecules · doi:10.1021/bm049305m · Cited by 180
Nose-to-brain peptide delivery – The potential of nanotechnology
Samaridou, E., & Alonso, M. J. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.11.001 · Cited by 183
Self-citationGaspar, M. M., Blanco, D., Cruz, M. E. M., & Alonso, M. J. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00196-x · Cited by 182
Self-citationYang, R., Zhang, S., Kong, D., Gao, X., Zhao, Y., & Wang, Z. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0848-8 · Cited by 172
García-Fuentes, M., Prego, C., Torres, D., & Alonso, M. J. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.02.008 · Cited by 170
Self-citationBiodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification
Lamprecht, A., Ubrich, N., Pérez, M. H., Lehr, C., Hoffman, M., & Maincent, P. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00107-6 · Cited by 169
Fibrinogen adsorption and host tissue responses to plasma functionalized surfaces
Tang, L., Wu, Y., & Timmons, R. B. (1998) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(199810)42:1 · Cited by 127
Self-citationChitosan-dextran Sulfate Nanoparticles for Delivery of an Anti-angiogenesis Peptide
Chen, Y., Mohanraj, V. J., & Parkin, J. E. (2003) · International Journal of Peptide Research and Therapeutics · doi:10.1007/bf02442596 · Cited by 166
Synthesis of Shell Cross-Linked Micelles at High Solids in Aqueous Media
Bütün, V., Wang, X. S., Báñez, M. V. D. P., Robinson, K. L., Billingham, N. Ć., Armes, S. P., & Tuzar, Z. (1999) · Macromolecules · doi:10.1021/ma9914669 · Cited by 166
Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha
Sánchez, A., Tobío, M. T. B., González, L., Fabra, À., & Alonso, M. J. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(03)00019-8 · Cited by 162
Self-citationPenetratin-functionalized PEG–PLA nanoparticles for brain drug delivery
Xia, H., Gao, X., Gu, G., Liu, Z., Hu, Q., Tu, Y., Song, Q., Yao, L., Pang, Z., Jiang, X., et al. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.029 · Cited by 163
New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin
García-Fuentes, M., Torres, D., & Alonso, M. J. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.12.030 · Cited by 162
Self-citationMeng, F., Hui, G., Qiu, W., & Su, Z. G. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00273-6 · Cited by 160
Pharmaceutical Aspects of Intranasal Delivery of Vaccines Using Particulate Systems
Sharma, S., Mukkur, T. K. S., Benson, H. A., & Chen, Y. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21493 · Cited by 160
Investigation of polymeric nanoparticles as carriers of enalaprilat for oral administration
Grabnar, P. A., Kristl, J., Kristl, A., & Vrečer, F. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00076-5 · Cited by 157
Pawar, D., Mangal, S., Goswami, R., & Jaganathan, K. S. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.06.017 · Cited by 156
Nanomedicine: Novel approaches in human and veterinary therapeutics
Irache, J. M., Esparza, I., Gamazo, C., Agüeros, M., & Espuelas, S. (2011) · Veterinary Parasitology · doi:10.1016/j.vetpar.2011.05.028 · Cited by 154
Wang, S., Liu, H., Zhang, X., & Qian, F. (2015) · Protein & Cell · doi:10.1007/s13238-015-0164-2 · Cited by 157
PLA-PEG particles as nasal protein carriers: the influence of the particle size
Vila, A., Sánchez, A., Évora, C., Soriano, I., McCallion, O. N. M., & Alonso, M. J. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.09.002 · Cited by 150
Self-citationInjectable formulations of poly(lactic acid) and its copolymers in clinical use
Jain, A., Kunduru, K. R., Basu, A., Mizrahi, B., Domb, A. J., & Khan, W. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.07.002 · Cited by 149
Kong, L., Alves, C. S., Hou, W., Qiu, J., Möhwald, H., Tomás, H., & Shi, X. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/am508760w · Cited by 146
Modulating the immune system through nanotechnology
Dacoba, T. G., Ana, O., Torres, D., Crecente‐Campo, J., & Alonso, M. J. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.09.007 · Cited by 150
Self-citationYoncheva, K., Lizarraga, E., & Irache, J. M. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.12.002 · Cited by 145
Nanoparticles as carriers for nasal vaccine delivery
Köping‐Höggård, M., Sánchez, A., & Alonso, M. J. (2005) · Expert Review of Vaccines · doi:10.1586/14760584.4.2.185 · Cited by 140
Self-citationEmerging Technologies of Polymeric Nanoparticles in Cancer Drug Delivery
Brewer, E. C., Coleman, J., & Lowman, A. M. (2010) · Journal of Nanomaterials · doi:10.1155/2011/408675 · Cited by 139
New lipid nanocapsules exhibit sustained release properties for amiodarone
Lamprecht, A., Bouligand, Y., & Benoît, J. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00258-4 · Cited by 138
Davaran, S., Asgari, D., Davaran, S., Akbarzadeh, A., Zarghami, Mikaeili, H., & Mohamad, R. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s24326 · Cited by 134
RetractedGiovino, C., Ayensu, I., Tetteh, J., & Boateng, J. S. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.02.035 · Cited by 132
M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery
Jepson, M. A., Clark, M. A., & Hirst, B. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.018 · Cited by 130
Rabanel, J., Adibnia, V., Tehrani, S. F., Sanche, S., Hildgen, P., Banquy, X., & Ramassamy, C. (2018) · Nanoscale · doi:10.1039/c8nr04916e · Cited by 132
Wang, C., Le-song, H., Hou, L., Jiang, L., Yan, Z.-T., Wang, Y.-L., & Chen, Z.-L. (2009) · Brain Research · doi:10.1016/j.brainres.2009.01.011 · Cited by 129
The performance of nanocarriers for transmucosal drug delivery
Csaba, N., García-Fuentes, M., & Alonso, M. J. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.4.463 · Cited by 126
Self-citationNanogels as novel drug nanocarriers for CNS drug delivery
Vasanthan, M., Nivetha, R. P., Tamilanban, T., Narayanan, J., Subramaniyan, V., Fuloria, N. K., Chinni, S. V., Sekar, M., Fuloria, S., Wong, L. S., et al. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1232109 · Cited by 130
Jaiswal, J. K., Gupta, S. K., & Kreuter, J. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.01.017 · Cited by 126
Metadata
- Authors
- Tobío, M., Gref, R., Sánchez, A., Langer, R., & Alonso, M. J.
- Affiliations
- Universidade de Santiago de Compostela (ES)
- Laboratoire de Chimie-Physique Macromoléculaire (FR)
- Massachusetts Institute of Technology (US)
- Venue
- Pharmaceutical Research
- Published
- 1998-02
- Volume
- 15
- Issue
- 2
- Pages
- 270-275
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W1494872149
- Cited by
- 402
- References
- 19
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 10 · 2023: 9 · 2022: 4 · 2021: 6 · 2020: 7 · 2019: 15 · 2018: 14 · 2017: 15 · 2016: 22 · 2015: 13 · 2014: 25 · 2013: 24 · 2012: 31
- FWCI
- 10.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Pharmaceutical Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM026698, GM 26698)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Keywords
- polylactic acid, protein encapsulation, tetanus toxoid, nasal mucosa, intranasal drug delivery, carrier proteins, surface hydrophobicity, lymph node uptake, blood circulation, colloidal carriers
- MeSH terms
- Administration, Intranasal, Animals, Drug Carriers, Lactates, Microscopy, Electron, Particle Size, Polyethylene Glycols, Tetanus Toxoid, Tissue Distribution, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
